Sudha Devi Janga
About Sudha Devi Janga
Data last updated:
Sudha Devi Janga was a Designated Partner at Ps3 Laboratories Llp (2015–2024) and Director at Aptus Therapeutics Private Limited (2014–2016). The companies operate in Travel and Hospitality and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ps3 Laboratories Llp AAE-1740 | Designated Partner | 15 Jun 2015 | 2015 | Active | |
| Aptus Therapeutics Private Limited U24232TG2010PTC071724 | Director | 01 Aug 2014 | 2010 | ₹31.8 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudha Devi Janga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudha Devi Janga
Sudha Devi Janga was first appointed on 01 Aug 2014 as Director at Aptus Therapeutics Private Limited. The most recent appointment on record is 15 Jun 2015 at Ps3 Laboratories Llp.
Sudha Devi Janga held 2 earlier board appointments: Ps3 Laboratories Llp (Designated Partner, 15 Jun 2015 to 13 Sep 2024); Aptus Therapeutics Private Limited (Director, 01 Aug 2014 to 26 Dec 2016).